Post-approval studies (Phase 4)UnknownNCT05075057
What this trial is testing
Immunogenicity and Safety of an Inactivated COVID-19 Vaccine in Patients Aged ≥60 Years With Chronic Bronchitis and COPD
Who this might be right for
COVID-19Chronic BronchitisCopd
China National Biotec Group Company Limited 400